Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jin Medical InternationalZJYL -3.80%66 EV-to-EBIT is 399.13 as of Aug. 29, 2026, which is 1079% above its 10-year median of 33.85. GuruFocus rates ZJYL with a GF Score™ of 66/100 and a GF Value™ of $12.85 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 480 Medical Devices & Instruments companies, Jin Medical International ranks worse than 97.92% on this metric.
Jin Medical International (NAS:ZJYL) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Jin Medical International's Enterprise Value for the quarter that ended in Mar. 2026 was $4.42 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Jin Medical International's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $0.42 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jin Medical International EV-to-EBIT Related Terms
Jin Medical International EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Jin Medical International's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jin Medical International EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Jin Medical International's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Jin Medical International's EV-to-EBIT falls into.
Jin Medical International's current Enterprise Value is $166.84 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Jin Medical International's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $0.42 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jin Medical International (ZJYL) has a EV-to-EBIT of 399.13 as of Aug. 29, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Jin Medical International and its competitors. This is 1079% above median its historical median of 33.85. Over the past decade, Jin Medical International's EV-to-EBIT has ranged from 6.08 to 658.84. According to the industry distribution chart, Jin Medical International ranks #470 out of 480 companies in the Medical Devices & Instruments industry, placing it in the top 97.9%.
Is Jin Medical International's EV-to-EBIT too high?
Jin Medical International's current EV-to-EBIT of 399.13 is 1079% above median its 10-year median of 33.85. Over the past 10 years, this metric has ranged from a low of 6.08 to a high of 658.84. The Medical Devices & Instruments industry median EV-to-EBIT is 18.86. Jin Medical International's value of 399.13 is 2016.3% above this industry median. Based on the distribution chart, Jin Medical International ranks #470 out of 480 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Jin Medical International has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jin Medical International's EV-to-EBIT compare to RGNT and BNGO?
According to the Medical Devices & Instruments industry distribution chart, Jin Medical International ranks #470 out of 480 companies for EV-to-EBIT. This places Jin Medical International in the lower half of its industry. The industry median EV-to-EBIT is 18.86. Jin Medical International's value of 399.13 is 2016.3% above this benchmark. Historically, Jin Medical International's own EV-to-EBIT has ranged from 6.08 to 658.84 over the past decade. While the company's 10-year median is 33.85 vs. the industry median of 18.86, Jin Medical International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.86, based on 480 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jin Medical International's current EV-to-EBIT of 399.13 is 2016.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Jin Medical International and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jin Medical International's current EV-to-EBIT is 399.13, which is 1079% above median its own 10-year median of 33.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jin Medical International stock overvalued right now?
Based on GuruFocus' analysis, Jin Medical International (ZJYL) is currently considered Significantly Undervalued. The stock's GF Value™ is $12.85, compared to a current price of $2.36 — trading 81.6% below its estimated fair value. The current EV-to-EBIT is 399.13, which is 1079% above median its 10-year median of 33.85 and 2016.3% above the Medical Devices & Instruments industry median of 18.86. Jin Medical International's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Jin Medical International (ZJYL), the current EV-to-EBIT is 399.13 as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jin Medical International (ZJYL) Overvalued in 2026?
Based on GuruFocus' analysis, Jin Medical International stock appears to be undervalued.
The current stock price of $2.36 is trading 81.6% below its estimated GF Value™ of $12.85.
GuruFocus considers Jin Medical International to be Significantly Undervalued.
Key valuation signals for ZJYL:
EV-to-EBIT: 399.13 (1079% above median its 10-year median of 33.85)
GF Value™: $12.85 vs. price of $2.36 (81.6% below fair value)
Industry Position: 2016.3% above the Medical Devices & Instruments median (#470 of 480)
No single metric tells the full story. See the ZJYL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jin Medical International Ltd, along with its subsidiaries, mainly offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other assistive living aid products for use by people with disabilities or impaired mobility. The group's product offering includes wheelchairs and wheelchair components, oxygen concentrators, bathing machines, respiratory and walking aids, oxygen chambers, beauty instruments, and nano products, among others. Wheelchairs are currently its key revenue-generating product. The products are sold to dealers in Japan and China, and to some extent to dealers located in the United States, Canada, Australia, Korea, Israel, Singapore, and other regions. Geographically, the group generates maximum revenue from Japan.
66GF Score
Get the complete analysis for ZJYL
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ZJYL has been successfully added to your 
